StockData
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd (TLX) stock

TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.96+0.11 (+1.19%)

Close on Nov 18, 2026Market cap $3.04BP/E –Yield –

Telix Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Telix Pharmaceuticals's cash was $251.91M at Jun 30, 2026. For fiscal 2025 it was $141.87M, down 67.8% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$141.87M-67.8%
FY2024Dec 31, 2024$440.00M+422.0%
FY2023Dec 31, 2023$84.30M+7.0%
FY2022Dec 31, 2022$78.78M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$251.91M+198.8%
Q4 FY2025Dec 31, 2025$141.87M+80.1%
Q2 FY2025Jun 30, 2025$207.16M–
Q4 FY2024Dec 31, 2024$440.00M–
Q4 FY2023Dec 31, 2023$84.30M–
Q4 FY2022Dec 31, 2022$78.78M–

More Telix Pharmaceuticals figures

See a number that looks wrong?